中医药治疗围绝经期综合征研究进展

来源 :辽宁中医药大学学报 | 被引量 : 0次 | 上传用户：smsyzgc

【摘要】

：

围绝经期综合征(menopausal syndrome,MPS)是指女性绝经前后因激素波动所致的一系列躯体及精神心理症状,其根本原因是生理性、病理性或手术引起的卵巢功能衰竭或耗竭,并伴随着较为复杂的并发症.发病时间久,对女性的身心健康危害很大,属难治之证,现代临床主要以心理疏导和激素治疗作为主要手段,然不良反应和危险性也不可避免.中医药凭借其独特优势在MPS的治疗中起到了良好效果.文章对近几年内国内外文献进行回顾和分析,对其归纳总结并就其治疗机制进行综述.

【作者】

：

李冀潘明月李想王晓雨付强

【机构】

：

黑龙江中医药大学,黑龙江哈尔滨150040

【出处】

：

辽宁中医药大学学报

【发表日期】

：

2021年9期

【关键词】

：

围绝经期综合征中医药作用机制研究进展

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

Drug-induced Fatty Liver Disease: Pathogenesis and Treatment

Metabolic dysfunction-associated fatty liver disease (com-monly known as MAFLD) impacts global health in epidemic proportions, and the resulting morbidity, mortality and eco-nomic burden is enormous. While much attention has been given to metabolic syndro

期刊

Metabolic dysfunction-associated fatty liver diseaseDrug-induced liver injuryR

Clinicopathological and Prognostic Value of Programmed Cell Death 1 Expression in Hepatitis B Virus-

Background and Aims: The efficacy of targeted pro-grammed cell death 1/programmed death ligand 1 (PD-1/PD-L1) monoclonal antibodies (mAbs) has been confirmed in many solid malignant tumors. The overexpression of PD-1/PD-L1 serves as a biomarker to predict

期刊

Hepatocellular carcinomaHepatitis B virusProgrammed cell death protein 1Progn

Epidemiology and Clinical Outcomes of Metabolic (Dysfunction)-associated Fatty Liver Disease

Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is currently the most common chronic liver disease and affects at least a quarter of the global adult population. It has rapidly become one of the leading causes of hepa-tocellular carcinoma a

期刊

Nonalcoholic fatty liver diseaseNonalcoholic steatohepatitisObe-sityPrevalenc

Characteristics and Outcome of Exertional Heatstroke Patients Complicated by Acute Hepatic Injury: A

Background and Aims: Exertional heatstroke (EHS) is as-sociated with strenuous physical activity in hot environments. The present study aimed to investigate dynamic changes of hepatic function indices in EHS patients and determine risk factors for death.

期刊

Exertional heatstrokeAcute hepatic injuryMortalityTBILSOFA

Pharmacological Therapeutics: Current Trends for Metabolic Dysfunction-associated Fatty Liver Diseas

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new term from nonalcoholic fatty liver disease (NAFLD) and is a positive diagnosis based on histopathology, imaging, or blood biomarkers. MAFLD is one of the common causes of liver dysfunct

期刊

Metabolic dysfunction-associated fatty liver diseaseNonalcoholic fatty liver di

Novel Agents in the Management of Hepatic Encephalopathy: A Review

Hepatic encephalopathy is an often devastating complication of chronic liver disease, associated with high mortality and in-creased burden on patients and healthcare systems. Current agents (such as nonabsorbable disaccharides and oral anti-biotics) are o

期刊

Hepatic encephalopathyLiver cirrhosisAmmonia

Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review

Hepatocellular carcinoma (HCC) is one of the leading caus-es of cancer deaths worldwide and liver transplantation (LT) is the only potentially curative treatment. Over the years, Milan criteria has been used for patient selection. There is ongoing researc

期刊

Hepatocellular carcinomaLiver transplantationModel for end-stage liver disease

COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence

The liver is frequently affected by severe acute respira-tory syndrome-coronavirus 2 (SARS-CoV-2) infection. The most common manifestations are mildly elevated alanine aminotransferase and aspartate aminotransferase, with a prevalence of 16-53％ among pati

期刊

COVID-19SARS-CoV-2Liver hepatitisLiver injuryNovel coro-navirus

Guidelines for Prevention and Treatment of Chronic Hepatitis B

To achieve the goal of the World Health Organization to eliminate viral hepatitis as a major public health threat by 2030, the Chinese Society of Infectious Diseases and the Chinese Society of Hepatology convened an expert panel in 2019 to update the guid

期刊

Hepatitis BChronicGuidelinesPreventionTreatment

胆管癌的光动力治疗

胆管癌是种恶性程度很高的消化道肿瘤,且超过一半的患者在诊断时已是疾病晚期,错失了手术的机会.光动力疗法(PDT)是一种局部消融方法,它使用系统性光敏剂,优先聚集在恶性细胞中,并被非热光激活,通过氧自由基介导的过程导致恶性细胞的破坏.胆管癌的PDT潜在治疗方案包括联合化疗、联合支架植入、复发肿瘤的术后治疗,或对患者进行治疗使肿瘤降期后行根治性手术.在治疗胆汁淤积的同时,PDT疗法可提高生存率和生活质量,并减少肿瘤生长.

期刊

胆管癌光动力疗法肝切除支架化疗肝移植

中医药治疗围绝经期综合征研究进展

其他学术论文